SCHEMBL2002569

SCHEMBL2002569

Oc1cccnc1-c1cc2ccccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITK Q08881 10/20 0.60
▸ RIPK1 Q13546 1/20 0.51
▸ CYP19A1 P11511 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ USP2 O75604 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ GSK3B P49841 1/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ P2RY1 P47900 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5179280 0.83 ITK (0.61) ITKCYP19A1KDM4EMEN1ALDH1A1
SCHEMBL3004549 0.82 RIPK1 (0.69) RIPK1DAO
SCHEMBL25416927 0.82 ITK (0.61) ITKRIPK1CYP19A1KDM4EMEN1
SCHEMBL2876288 0.81 ITK (0.60) ITKCYP19A1GSK3BNPC1RAB9A
SCHEMBL8638212 0.81 ITK (0.60) ITKCYP19A1KDM4EMEN1ALDH1A1
SCHEMBL2003314 0.77 RIPK1 (0.55) ITKRIPK1CYP19A1KDM4EMEN1
SCHEMBL30116104 0.77 ITK (0.56) ITKCYP19A1GSK3BNPC1RAB9A
SCHEMBL14765019 0.76 KDM4E (0.50) ITKCYP19A1KDM4EMEN1USP2
SCHEMBL2489128 0.75 ITK (0.57) ITKCYP19A1KDM4EMEN1USP2
SCHEMBL30337474 0.75 ITK (0.57) ITKCYP19A1KDM4EMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 — — EP disclosed
CN-102850324-A Indole compounds MICROBIA INC 2013-01-02 — — CN disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 — — US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 — — US disclosed
CN-101563337-A Indole compounds MICROBIA INC (US) 2009-10-21 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 ITK 2540/4885RIPK1 1213/4885CYP19A1 700/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT ITK 3951/4885RIPK1 2317/4885CYP19A1 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback